Kao Opens New Tertiary Amine Production Plant in U.S. to Meet Global Growing Demand
Kao Corporation (TOKYO:4452) (President and CEO: Yoshihiro Hasebe) has built a new tertiary amine production plant in Pasadena, Texas, United States, the opening ceremony for which took place on August 22, 2025. The new plant, with an annual production capacity of 20,000 tons, will further enhance stable supply for the U.S. market, which is expected to grow in the mid- to long-term. In addition, local production in the U.S. will improve the efficiency of Kao’s supply chain and reduce transportation-related CO2 emissions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250824920248/en/
New tertiary amine production plant in Texas
Tertiary amines are important chemical ingredients used in surfactants such as disinfectants and cleaners. Until now, Kao has had the world’s largest production capacity, with three production sites in Japan, the Philippines and Germany employing Kao’s unique technology to produce tertiary amines of superior quality. Kao uses tertiary amines in its own products and has also supplied industries around the world through its Chemical Business. Its new U.S. plant will create a three-production-site system with plants in the U.S., Europe and Asia, to ensure a more stable and speedier supply of tertiary amines to global markets.
For Kao’s Chemical Business, tertiary amines are a core component of Global Sharp Top*1, the focus of Kao’s Mid-term Plan 2027 (K27). The new plant will make a major contribution to ensure further stability of the Chemical Business’s global business base.
*1
“Global Sharp Top” is Kao’s business strategy for achieving meaningful and sustainable global growth by focusing on businesses that deliver critical solutions in markets facing rapidly evolving social challenges.
Comment from Daisuke Hamada, President, Chemical Business
Construction work on the Pasadena plant took two and a half years, and I am very happy to see the work successfully completed. The plant, which combines Kao’s unique technologies with a long-running safety record and quality control knowhow, will be the key point of a global supply chain ensuring a more stable supply of tertiary amines not only for the North American market but also for a broad range of industries all over the world.
The Pasadena site, where the plant is located, covers an area of 45 hectares, and Kao is also considering utilizing the site not only for tertiary amine production but also as a platform for working together with outside partners to produce derivatives. By leveraging this platform, we are confident it will strengthen the value chain of the entire ecosystem.
The Chemical Business will continue resolutely taking on the challenges to fulfill its role in building the cornerstone of Kao’s global growth.
About Kao
Kao, a Japan-based manufacturer of personal care and household products, cosmetics, and specialty chemicals creates high-value-added products and services that provide care and enrichment for the life of all people and the planet. Through its brands such as Attack, Bioré, Jergens, Laurier, Curél, SENSAI, MOLTON BROWN, and Oribe, Kao is part of the everyday lives of people across Asia, the Americas, Europe, the Middle East, and Africa. The Chemical Business also contributes to a wide range of industries. Utilizing its capabilities in precise interface control technology, the Chemical Business applies its deep knowledge in the areas of fats and oils and polymers to provide a variety of products and solutions. From daily necessities to electronic materials, agricultural products, asphalt additives and more, Kao works to provide solutions for broad industry needs and social issues. With about 1,630 billion yen in annual sales, Kao employs about 32,600 people worldwide and has more than 130 years of history in innovation.
Please visit the Kao Group website for additional information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250824920248/en/
Contacts
Media inquiries should be directed to:
Public Relations
Kao Corporation
corporate_pr@kao.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press Release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform16.12.2025 02:00:00 CET | Press Release
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. Furthermore, Esco Aster is providing technical services for exploratory exosome loading feasibility studies per Shine-On’s instruction. Shine-On Biomedical is an emerging innovator in exosome-based drug delivery. ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G targeted exosome platfo
Civil Air Patrol Expands Fleet With 15 New Cessna Aircraft to Support Lifesaving and Community Missions15.12.2025 17:00:00 CET | Press Release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced today that Civil Air Patrol (CAP), the world’s largest operator of Cessna aircraft, is strengthening its national mission capabilities with an order for 15 additional piston-engine aircraft, including seven Cessna Skyhawk 172 and eight Cessna Skylane 182 models scheduled for delivery throughout 2026. The order follows recent deliveries of an additional two Cessna Skylane and one Cessna Turbo Stationair HD aircraft, expanding CAP’s fleet to more than 500 Cessna aircraft nationwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215613573/en/ Delivery of an additional two Cessna Skylane and one Cessna Turbo Stationair HD aircraft joins CAP’s fleet of more than 500 Cessna aircraft nationwide. Cessna aircraft are designed and produced by Textron Aviation. “Civil Air Patrol’s missions demand aircraft that are reliable, versatile and ready to perform in critic
Winston & Strawn and Taylor Wessing UK to Combine, Creating a Premier Transatlantic Law Firm15.12.2025 16:52:00 CET | Press Release
Winston & Strawn and Taylor Wessing’s UK-led business announced today their intention to combine, creating a premier transatlantic law firm that would operate under a new shared name, Winston Taylor. The combination responds to increasing client demand for seamlessly integrated US–UK–EU counsel for the businesses, people, and markets driving capital and innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215914957/en/ The combination once final will unite two international firms with more than 400 years of combined history, complementary strengths, and a common vision to meet clients’ evolving global needs. The combined firm will include more than 1,400 lawyers, establishing one of the largest transatlantic firms whose footprint is primarily in the United States, the United Kingdom, and Europe, and also in Latin America and the Middle East. Leveraging significant strength and scale in major litigation, critical tra
Despite Barriers, Financial Institutions are Clear About AI's Greatest Impact15.12.2025 16:32:00 CET | Press Release
HTEC, a global AI-first provider of software and hardware design and engineering services, today released The State of AI in Financial Services & Insurance 2025, a first industry subset of its global research report in AI. This publication offers one of the clearest views to date into how financial institutions are adopting and scaling artificial intelligence. This industry-focused report analyzes insights from 250 C-suite leaders within financial services and insurance, drawn from HTEC’s broader global study of 1,529 C-suite executives—including CIOs, CTOs, CDOs, CPOs, CFOs, COOs, CEOs and CSOs—across Saudi Arabia, the UAE, the United Kingdom, the United States, Germany and Spain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215790717/en/ Executive Summary: The State of AI in Financial Services and Insurance 2025 The findings confirm a decisive shift in the industry: not a single respondent said AI is not a priority. L
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom